Facebook Twitter Google+ Post Views: 1,194 EuropeWHO Share the News Facebook Twitter VKontakte Google+ ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen WHO: The use of delamanid in the treatment of MDR-TB in children and adolescents: Interim policy guidance Related News 1793 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 1701 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2179 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection 1455 Behavioral intervention reduces HIV transmission risk in young transgender women 1892 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 1793 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 1701 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2179 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection 1455 Behavioral intervention reduces HIV transmission risk in young transgender women 1892 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 1793 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe
1892 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
1892 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
